Page last updated: 2024-08-17

rotenone and ER-Negative PR-Negative HER2-Negative Breast Cancer

rotenone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alimirah, F; Katta, H; Mehta, R; Mehta, RG; Murillo, G; Muzzio, M; Patel, R; Peng, X	1
Cai, S; Cichewicz, RH; Mooberry, SL; Robles, AJ	1

Other Studies

2 other study(ies) available for rotenone and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells. PloS one, 2013, Volume: 8, Issue:6 Topics: Animals; Apoptosis; Blotting, Western; Cell Proliferation; ErbB Receptors; Female; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Mice; Mice, Nude; NF-kappa B; Proto-Oncogene Proteins c-met; Proto-Oncogene Proteins c-myc; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Rotenone; Signal Transduction; STAT3 Transcription Factor; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2013
Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer. Breast cancer research and treatment, 2016, Volume: 157, Issue:3 Topics: Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Nitriles; Phenylthiohydantoin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Rotenone; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2016

Article

Year

Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.

PloS one, 2013, Volume: 8, Issue:6

Topics: Animals; Apoptosis; Blotting, Western; Cell Proliferation; ErbB Receptors; Female; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Mice; Mice, Nude; NF-kappa B; Proto-Oncogene Proteins c-met; Proto-Oncogene Proteins c-myc; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Rotenone; Signal Transduction; STAT3 Transcription Factor; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2013

Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer.

Breast cancer research and treatment, 2016, Volume: 157, Issue:3

Topics: Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Nitriles; Phenylthiohydantoin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Rotenone; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2016